About the role
2027 MBA Summer Intern Program
Investment Analyst, Global Healthcare (Non-Therapeutics) Long/Short Equity
New York, NY
Founded in 1997, Marshall Wace is a leading global alternatives investment manager specializing in long/short equity. We combine fundamental investing with systematic and quantitative strategies to deliver returns from a range of investment solutions. We are one of the world’s largest alternative asset managers, managing in excess of $60 billion with around 420 employees working across London, New York, Hong Kong, Shanghai and Singapore.
Our history is one of continuous development and innovation, from being the creators of the TOPS Alpha Capture System, to the extensive use of proprietary systems throughout our investment and operations environment. In a challenging industry we seek to be competitive by bringing together people from diverse backgrounds and providing them with the systems, data, technology, and work environment they need to succeed. Our culture enables innovative ideas to surface from all areas of the firm and to be executed quickly. TOPS is an exceptional example of how innovation within Marshall Wace has created a unique investment solution for clients and driven many areas of the firm to improve efficiency and key processes and controls.
In September 2015, KKR and Marshall Wace announced the formation of a long term strategic partnership, with KKR initially acquiring 25pct in Marshall Wace. KKR has market leadership positions in Private Equity and Credit markets, which complement Marshall Wace’s market leadership position in Equity Long/Short, liquid alternative products. The strategic partnership is based on a shared vision of how financial markets are changing and how best to serve clients’ evolving investment requirements, bringing together strong traditions of investment expertise, innovation, entrepreneurship, and cultural alignment. In time, it will enable the joint development of new products, the potential for an expanded global client base, and allow the creation of incentive plans for the next generation of Marshall Wace partners and staff.
The Internship Program
Our 10-week Summer Internship Program is based in our New York City office. The goal of the program is to provide high performing, entrepreneurial MBA students with the breadth, variety and the support that will enable them to build a strong technical platform from which to launch their career.
Our program includes the following: - Business critical projects with the opportunity to produce high-impact work - Highly personalized mentoring within a lean, flat team structure - Weekly lunch seminars with senior managers and key staff across all teams - Opportunities to participate in the firm’s charitable activities and company-wide social events - Interaction with clients and service providers across the alternative asset management industry - Start Date: Monday, June 14th, 2027 - End Date: Friday, August 22nd, 2027
Global Healthcare
Marshall Wace’s fundamental strategies are designed to capture stock based idiosyncratic alpha and are concentrated in specific regions and sectors. Each fundamental strategy team is managed by a Portfolio Manager and supported by a number of Analysts with distinct areas of expertise. We seek to achieve exceptional returns at all stages of the investment process through creative idea generation, rigorous due diligence, company meetings, detailed financial modeling, disciplined portfolio construction and efficient trading and implementation.
The MW Global Healthcare long/short equity strategy invests in all sub-sectors of healthcare, including biotech, pharma, medtech, tools, diagnostics, hospitals, managed care and other healthcare services. The team conducts deep fundamental research that includes identifying shifts in market trends, modeling key business and financial drivers for various subsectors, building financial models, analyzing scientific/clinical data, and meeting with management teams.
During this internship, students will gain broad exposure to investment research, stock selection, portfolio construction, and risk management.
Responsibilities : - Generate long and short equity investment recommendations supported by detailed financial modeling and proprietary research - Active and ongoing monitoring of portfolio holdings - Participate in quarterly earnings calls and monitor news events related to companies under coverage, updating the models accordingly - Attend industry conferences and management meetings, build relationships with sell-side analysts and research associates - Conduct extensive and differentiated bottoms-up financial analysis of companies, business models, relevant industry metrics and industries
Requirements:
To be successful in this role you will need to be highly analytical, with the ability to think critically and creatively as well as be conversant with the principles of finance. Students pursuing a Masters of Business Administration are encouraged to apply. Successful applicants share some common traits: - Excellent academic credentials and pursuing an MBA degree at a top university - Background in Healthcare is not required - Strong written and verbal communication skills - Demonstrated interest in and enthusiasm for the public market investing and fundamental analysis - Advanced understanding of accounting/financial statements with the ability to identify key drivers of a business and industry - Excellent Excel modeling skills - A self-starter mentality with an ability to learn quickly in a fast-paced environment - Collaborative, team-oriented personality
If your application is shortlisted you will be invited to participate in a telephone interview before further steps of the process, which will include role-specific assessments and interviews in our New York City office.
From the firm's own listing feed. The posting itself is the version that counts.